非ステロイド性抗炎症薬（NSAID）市場は、シクロオキシゲナーゼ酵素を阻害してプロスタグランジン合成を抑制し、免疫抑制などのステロイド関連の副作用なしに、痛み、発熱、炎症を緩和する幅広い薬剤群を網羅しています。イブプロフェンやナプロキセンといった従来の非選択的阻害薬から、セレコキシブといった選択的COX-2遮断薬まで、これらの薬剤は、変形性関節症、関節リウマチ、急性痛風、術後疼痛といった急性および慢性疾患に効果を発揮します。また、市販薬の中には、軽度の筋骨格系の問題に対する自己管理を可能にするものもあります。市場の多様性は、さまざまな吸収ニーズに応える多様な製剤（経口錠剤、局所ジェル、坐剤）にあり、一方で慢性使用者の 15 〜 30% に影響を与える胃腸リスクを軽減するために胃保護コーティングに重点が置かれています。関節炎試験では、50〜70%の疼痛軽減が効果の根拠となっていますが、FDAのブラックボックス警告による心血管系および腎臓への注意喚起のため、HAS-BLEDスコアなどのツールを用いたリスク層別化が必要です。このセクターは、処方箋医薬品と市販薬の二重販売モデルで成長しており、特許切れ後の販売数量の80%をジェネリック医薬品が占めています。高齢化や運動不足の生活習慣に伴う筋骨格系疾患の増加が見込まれる中、手頃な価格を実現しています。20%のシェアを獲得している局所NSAIDsは、全身曝露量が10%未満で局所的な緩和効果をもたらすため、経口多剤併用療法を避けたい高齢者に最適です。 2025年までに、世界のNSAID市場は25億米ドルから50億米ドルに達すると推定され、2030年までの年平均成長率（CAGR）は4.5%から6.5%と予測されています。この力強い成長軌道は、慢性疼痛の負担増大（世界の成人の20%に影響）と、ACRによるマルチモーダル低用量レジメンへのガイドライン移行、そして生物学的製剤に類似した局所用薬のバイオシミラーの台頭によって支えられています。市場環境は、アクセス性と医薬品安全性監視のバランスをとっており、実世界のデータベースでは、患者教育アプリを通じて服薬遵守が25%向上したことが明らかになっています。NSAIDはアクセスしやすい鎮痛剤の典型であり、プライマリケアにおけるオピオイド依存を30%削減していますが、偽造品の脅威により、発展途上地域での公平なアクセスは遅れています。
NSAIDバリューチェーンは、芳香族合成から消費者エンパワーメントまでを統合的に行い、拡張性と安全性シグナル伝達を最適化しています。上流研究開発では、in silicoドッキングを用いてピラゾール骨格のCOX選択性をスクリーニングし、マッキンゼーがモデル化したプラットフォームを用いて第III相非劣性試験を加速させています。ジェネリック医薬品のコストは1億ドル未満で、外用薬については505(b)(2)を活用しています。臨床試験では、OMERACTに基づくVASエンドポイント、便潜血を用いた消化管出血の代替指標を活用し、FDAのGDUFA（一般用医薬品開発・承認申請）に基づきANDA（一般用医薬品承認申請）を簡素化しています。中間工程では、ヤナギ類似体からアスピリンサリチル酸を生産し、連続反応器でアセチル化して純度99%まで精製します。インドのサンファーマなどの拠点では、500トンのAPIを生産し、ジェネリック医薬品はプロセス特許を取得しています。製剤は、セレコキシブを腸溶コーティングしてpH 6以上で放出し、浸透促進剤を添加したゲルです。ウォルグリーンなどの小売チェーンへの下流常温物流、バイエルのDTCアプリによる使用状況追跡。マーケティング部門はPRECISIONの続編に関するACRシンポジウムを開催し、年間5,000ドルの収益を通じてHEORを獲得。サポートにはPPIの併用処方、投与量計算アプリ、腎症のためのFAERSなどが含まれる。Haleonのような垂直統合企業は、原材料価格の変動にも強いAPIからロイヤルティプログラムまでを統合している。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market in North America (2020-2030)
8.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market by End Use
8.3 Competition by Players/Suppliers
8.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market in South America (2020-2030)
9.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market by End Use
9.3 Competition by Players/Suppliers
9.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
Chapter 10 Historical and Forecast Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market in Asia & Pacific (2020-2030)
10.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market by End Use
10.3 Competition by Players/Suppliers
10.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market in Europe (2020-2030)
11.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market by End Use
11.3 Competition by Players/Suppliers
11.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market in MEA (2020-2030)
12.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
12.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market by End Use
12.3 Competition by Players/Suppliers
12.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Chapter 13 Summary For Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market (2020-2025)
13.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
13.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market by End Use
13.3 Competition by Players/Suppliers
13.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Chapter 14 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Forecast (2025-2030)
14.1 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size Forecast
14.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Application Forecast
14.3 Competition by Players/Suppliers
14.4 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Viatris
15.1.1 Company Profile
15.1.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.1.3 SWOT Analysis of Viatris
15.1.4 Viatris Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.2 Bayer
15.2.1 Company Profile
15.2.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.2.3 SWOT Analysis of Bayer
15.2.4 Bayer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.3 Haleon
15.3.1 Company Profile
15.3.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.3.3 SWOT Analysis of Haleon
15.3.4 Haleon Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.4 Pfizer
15.4.1 Company Profile
15.4.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.4.3 SWOT Analysis of Pfizer
15.4.4 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.5 Sandoz
15.5.1 Company Profile
15.5.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.5.3 SWOT Analysis of Sandoz
15.5.4 Sandoz Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.6 Teva Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.6.3 SWOT Analysis of Teva Pharmaceuticals
15.6.4 Teva Pharmaceuticals Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.7 Dr. Reddy's Laboratories
15.7.1 Company Profile
15.7.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.7.3 SWOT Analysis of Dr. Reddy's Laboratories
15.7.4 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.8 Sun Pharma
15.8.1 Company Profile
15.8.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.8.3 SWOT Analysis of Sun Pharma
15.8.4 Sun Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.9 Glenmark Pharma
15.9.1 Company Profile
15.9.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.9.3 SWOT Analysis of Glenmark Pharma
15.9.4 Glenmark Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
15.10 LUPIN
15.10.1 Company Profile
15.10.2 Main Business and Nonsteroidal Anti-Inflammatory Drugs (NSAID) Information
15.10.3 SWOT Analysis of LUPIN
15.10.4 LUPIN Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Report
Table Data Sources of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Report
Table Major Assumptions of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Nonsteroidal Anti-Inflammatory Drugs (NSAID) Picture
Table Nonsteroidal Anti-Inflammatory Drugs (NSAID) Classification
Table Nonsteroidal Anti-Inflammatory Drugs (NSAID) Applications
Table Drivers of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table Restraints of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table Opportunities of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table Threats of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table Raw Materials Suppliers
Table Different Production Methods of Nonsteroidal Anti-Inflammatory Drugs (NSAID)
Table Cost Structure Analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAID)
Table Key End Users
Table Latest News of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table Merger and Acquisition
Table Planned/Future Project of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table Policy of Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market
Table 2020-2030 North America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Figure 2020-2030 North America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and CAGR
Table 2020-2030 North America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2020-2025 North America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Revenue
Table 2020-2025 North America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Market Share
Table 2020-2030 North America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2020-2030 United States Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 South America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Figure 2020-2030 South America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and CAGR
Table 2020-2030 South America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2020-2025 South America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Revenue
Table 2020-2025 South America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Market Share
Table 2020-2030 South America Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2020-2030 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Asia & Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Figure 2020-2030 Asia & Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and CAGR
Table 2020-2030 Asia & Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2020-2025 Asia & Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Revenue
Table 2020-2025 Asia & Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Market Share
Table 2020-2030 Asia & Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2020-2030 China Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 India Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Australia Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Figure 2020-2030 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and CAGR
Table 2020-2030 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2020-2025 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Revenue
Table 2020-2025 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Market Share
Table 2020-2030 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2020-2030 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 France Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 United Kingdom Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Spain Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Belgium Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Netherlands Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Austria Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Poland Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Table 2020-2030 MEA Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size
Figure 2020-2030 MEA Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and CAGR
Table 2020-2030 MEA Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2020-2025 MEA Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Revenue
Table 2020-2025 MEA Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Players Market Share
Table 2020-2030 MEA Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Region
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size Share by Region
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share by Application
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Vendors Revenue
Figure 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and Growth Rate
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Vendors Market Share
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2020-2025 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share by Type
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Region
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size Share by Region
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Application
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share by Application
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Vendors Revenue
Figure 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size and Growth Rate
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Key Vendors Market Share
Table 2025-2030 Global Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Size by Type
Table 2025-2030 Nonsteroidal Anti-Inflammatory Drugs (NSAID) Global Market Share by Type
Table Viatris Information
Table SWOT Analysis of Viatris
Table 2020-2025 Viatris Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Viatris Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Viatris Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Bayer Information
Table SWOT Analysis of Bayer
Table 2020-2025 Bayer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Bayer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Bayer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Haleon Information
Table SWOT Analysis of Haleon
Table 2020-2025 Haleon Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Haleon Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Haleon Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Pfizer Information
Table SWOT Analysis of Pfizer
Table 2020-2025 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Sandoz Information
Table SWOT Analysis of Sandoz
Table 2020-2025 Sandoz Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Sandoz Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Sandoz Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Teva Pharmaceuticals Information
Table SWOT Analysis of Teva Pharmaceuticals
Table 2020-2025 Teva Pharmaceuticals Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Teva Pharmaceuticals Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Teva Pharmaceuticals Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Dr. Reddy's Laboratories Information
Table SWOT Analysis of Dr. Reddy's Laboratories
Table 2020-2025 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Sun Pharma Information
Table SWOT Analysis of Sun Pharma
Table 2020-2025 Sun Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Sun Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Sun Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table Glenmark Pharma Information
Table SWOT Analysis of Glenmark Pharma
Table 2020-2025 Glenmark Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 Glenmark Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 Glenmark Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
Table LUPIN Information
Table SWOT Analysis of LUPIN
Table 2020-2025 LUPIN Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue Gross Profit Margin
Figure 2020-2025 LUPIN Nonsteroidal Anti-Inflammatory Drugs (NSAID) Revenue and Growth Rate
Figure 2020-2025 LUPIN Nonsteroidal Anti-Inflammatory Drugs (NSAID) Market Share
......
